Table 3 Univariate analysis of disease-free, metastasis-free, and overall survival of patients with early invasive ductal breast cancer

Age

0.598

0.448

0.500

Tumor size

0.113

0.020*

0.069

Histological grade

0.178

0.291

0.207

HER2/neu status

0.536

0.293

0.103

ER status

0.336

0.191

0.175

PR status

0.691

0.946

0.521

Regional lymph nodes

0.595

0.805

0.620

OPG/TEpC

0.167

0.052

0.178

TRAIL/TEpC

0.465

0.648

0.304

RANKL/TEpC

0.156

0.267

0.307

SDF-1/TEpC

0.660

0.932

0.710

IL-6/TEpC CCL-2

0.873

0.710

0.487

CCL-2/TEpC

0.048*

0.071

0.507

TRAIL-R1/TEpC

0.536

0.339

0.626

TRAIL-R2/TEpC

0.894

0.749

0.392

TRAIL-R3/TEpC

0.009*

0.012*

0.015*

TRAIL-R4/TEpC

0.186

0.131

0.478

RANK/TEpC

0.546

0.991

0.804

CXCR-4/TEpC

0.164

0.255

0.175

IL-6R/TEpC

0.391

0.540

0.626

CCR-2/TEpC

0.013*

0.002*

0.049*

OPG/stromal cells

0.318

0.101

0.441

TRAIL/stromal cells

0.284

0.084

0.337

RANKL/stromal cells

0.139

0.052

0.222

SDF-1/stromal cells

0.792

0.734

0.306

IL-6/stromal cells CCL-2

0.218

0.093

0.168

CCL-2/stromal cells

0.104

0.076

0.505